Depression and Anxiety in Children at the End of Life

Pediatric Clinics of North America

Volumn 54, Issue 5, 2007, Pages 691-708

  Kersun, Leslie S ^a,b   Shemesh, Eyal ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; CYPROHEPTADINE; DIAZEPAM; FLUOXETINE; FLUVOXAMINE; KETANSERIN; LORAZEPAM; OXAZEPAM; PAROXETINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADJUSTMENT DISORDER; AGITATION; ANXIETY DISORDER; BEHAVIOR THERAPY; CHILD CARE; CHILD PSYCHIATRY; CLINICAL FEATURE; COGNITIVE THERAPY; COMA; CONFUSION; DEATH; DELIRIUM; DEPRESSION; DRUG WITHDRAWAL; DYING; DYSTHYMIA; EUTHANASIA; FEVER; GENERALIZED ANXIETY DISORDER; HALLUCINATION; HUMAN; HYPERTENSION; HYPERTHERMIA; INTERPERSONAL COMMUNICATION; MAJOR DEPRESSION; NAUSEA; PALLIATIVE THERAPY; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; RECOMMENDED DRUG DOSE; REVIEW; SEDATION; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SUICIDAL BEHAVIOR; SWEATING; SYMPTOM; TACHYCARDIA; TACHYPNEA; TERMINAL CARE; TERMINAL DISEASE;

ADJUSTMENT DISORDERS; ANXIETY DISORDERS; CHILD; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY; HUMANS; PREVALENCE; PSYCHOTHERAPY; STRESS DISORDERS, POST-TRAUMATIC; TERMINAL CARE;

EID: 35148812671     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2007.06.003     Document Type: Review

References (93)

1. Wolfe J., Grier H.E., Klar N., et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342 5 (2000) 326-333
2. Gothelf D., and Cohen I.J. Pediatric palliative care. N Engl J Med 351 3 (2004) 301-302 [author reply 301-2]
3. Lewis M. Dying and death in childhood and adolescence. In: Lewis M. (Ed). Child and adolescent psychiatry. 2nd edition (1996), Williams & Wilkins, Baltimore (MD) 1066-1073
4. Sourkes B. Psychotherapy with the dying child. In: Chochinov H., and Breitbart W. (Eds). Handbook of psychiatry in palliative medicine (2000), Oxford University Press, New York 265-272
5. Nagy M. The child's theories concerning death. J Genet Psychol 73 (1948) 3-27
6. Stevens M.M., et al. Psychological adaptation of the dying child. In: Doyle D., Hanks G., and Cherny N. (Eds). Oxford textbook of palliative medicine. 3rd edition (2004), Oxford University Press, Oxford (UK) 798-806
7. Waechter E. Children's awareness of fatal illness. Am J Nurs 71 (1971) 1168-1172
8. Waechter E. Children's reactions to fatal illness. In: Krulik T., Holaday B., and Martinson I. (Eds). The child and family facing life-threatening illness (1972), J.B. Lippincott Company, Philadelphia 108-119
9. Bluebond-Langer M. The private worlds of dying children (1978), Princeton University Press, Princeton (NJ)
10. Spinetta J.J. The dying child's awareness of death: a review. Psychol Bull 81 4 (1974) 256-260
11. Spinetta J.J., Rigler D., and Karon M. Anxiety in the dying child. Pediatrics 52 6 (1973) 841-845
12. Spinetta J., and Maloney L. Death anxiety in the outpatient leukemic child. Pediatrics 56 6 (1975) 1034-1037
13. Beale E.A., Baile W.F., and Aaron J. Silence is not golden: communicating with children dying from cancer. J Clin Oncol 23 15 (2005) 3629-3631
14. Mack J.W., and Grier H.E. The day one talk. J Clin Oncol 22 3 (2004) 563-566
15. Nitschke R., Meyer W.H., Sexauer C.L., et al. Care of terminally ill children with cancer. Med Pediatr Oncol 34 4 (2000) 268-270
16. Postovsky S., and Ben Arush M.W. Care of a child dying of cancer: the role of the palliative care team in pediatric oncology. Pediatr Hematol Oncol 21 1 (2004) 67-76
17. Hinds P.S., Schum L., Baker J.N., et al. Key factors affecting dying children and their families. J Palliat Med 8 Suppl 1 (2005) S70-S78
18. Theunissen J.M., Hoogerbrugge P.M., van Achterberg T., et al. Symptoms in the palliative phase of children with cancer. Pediatr Blood Cancer 49 2 (2007) 160-165
19. Drake R., Frost J., and Collins J.J. The symptoms of dying children. J Pain Symptom Manage 26 1 (2003) 594-603
20. Block S.D. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med 132 3 (2000) 209-218
21. Hilden J.M., Emanuel E.J., Fairclough D.L., et al. Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol 19 1 (2001) 205-212
22. Hedstrom M., Kreuger A., Ljungman G., et al. Accuracy of assessment of distress, anxiety, and depression by physicians and nurses in adolescents recently diagnosed with cancer. Pediatr Blood Cancer 46 7 (2006) 773-779
23. Shemesh E., Annunziato R.A., Shneider B.L., et al. Parents and clinicians underestimate distress and depression in children who had a transplant. Pediatr Transplant 9 5 (2005) 673-679
24. Shemesh E., Yehuda R., Rockmore L., et al. Assessment of depression in medically ill children presenting to pediatric specialty clinics. J Am Acad Child Adolesc Psychiatry 44 12 (2005) 1249-1257
25. Passik S.D., Donaghy K.B., Theobald D.E., et al. Oncology staff recognition of depressive symptoms on videotaped interviews of depressed cancer patients: implications for designing a training program. J Pain Symptom Manage 19 5 (2000) 329-338
26. Maguire P., Booth K., Elliott C., et al. Helping health professionals involved in cancer care acquire key interviewing skills-the impact of workshops. Eur J Cancer 32A 9 (1996) 1486-1489
27. Fallowfield L., Jenkins V., Farewell V., et al. Efficacy of a cancer research UK communication skills training model for oncologists: a randomised controlled trial. Lancet 359 9307 (2002) 650-656
28. Shemesh E., Bartell A., and Newcorn J.H. Assessment and treatment of depression in medically ill children. Curr Psychiatry Rep 4 2 (2002) 88-92
29. Canning E.H., and Kelleher K. Performance of screening tools for mental health problems in chronically ill children. Arch Pediatr Adolesc Med 148 3 (1994) 272-278
30. Phipps S., and Srivastava D.K. Approaches to the measurement of depressive symptomatology in children with cancer: attempting to circumvent the effects of defensiveness. J Dev Behav Pediatr 20 3 (1999) 150-156
31. Harris E.S., Canning R.D., and Kelleher K.J. A comparison of measures of adjustment, symptoms, and impairment among children with chronic medical conditions. J Am Acad Child Adolesc Psychiatry 35 8 (1996) 1025-1032
32. Yang Y.M., Cepeda M., Price C., et al. Depression in children and adolescents with sickle-cell disease. Arch Pediatr Adolesc Med 148 5 (1994) 457-460
33. Kuttner M., Delamater A., and Santiago J. Learned helplessness in diabetic youths. J Pediatr Psychol 15 (1990) 581-594
34. Kovacs M. Children's Depression Inventory (CDI) (1992), Multi-Health Systems, Inc., New York
35. Collins J.J., Byrnes M.E., Dunkel I.J., et al. The measurement of symptoms in children with cancer. J Pain Symptom Manage 19 5 (2000) 363-377
36. Collins J.J., Devine T.D., Dick G.S., et al. The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12. J Pain Symptom Manage 23 1 (2002) 10-16
37. Poznansky E., and Mokros H. Children's Depression Rating Scale-Revised (CDRS-R) (1995), Western Psychological Services, Los Angeles
38. Kaufman J., Birmaher B., Brent D., et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36 7 (1997) 980-988
39. Rodriguez N., Steinberg A., and Pynoos R. UCLA Post traumatic stress disorder reaction index for DSM-IV, child, adolescent and parent versions (1998), University of California, Los Angeles (CA)
40. Shemesh E., Annunziato R.A., Newcorn J.H., et al. Assessment of posttraumatic stress symptoms in children who are medically ill and children presenting to a child trauma program. Ann N Y Acad Sci 1071 (2006) 472-477
41. Spence S.H. A measure of anxiety symptoms among children. Behav Res Ther 36 5 (1998) 545-566
42. Birmaher B., Khetarpal S., Brent D., et al. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry 36 4 (1997) 545-553
43. March J. Multidimensional Anxiety Scale for Children (MASC) (1997), Multi-Health Systems Inc., North Tonawanda (NY)
44. Silverman W.K., and Nelles W.B. The anxiety disorders interview schedule for children. J Am Acad Child Adolesc Psychiatry 27 6 (1988) 772-778
45. Lyneham H.J., and Rapee R.M. Evaluation and treatment of anxiety disorders in the general pediatric population: a clinician's guide. Child Adolesc Psychiatr Clin N Am 14 4 (2005) 845-861 x
46. Steif B.L., and Heiligenstein E.L. Psychiatric symptoms of pediatric cancer pain. J Pain Symptom Manage 4 4 (1989) 191-196
47. Diagnostic and statistical manual of mental disorders: text revision. 4th edition (2000), American Psychiatric Association, Washington, DC
48. Weisz J.R., McCarty C.A., and Valeri S.M. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 132 1 (2006) 132-149
49. Poltorak D.Y., and Benore E. Cognitive-behavioral interventions for physical symptom management in pediatric palliative medicine. Child Adolesc Psychiatr Clin N Am 15 3 (2006) 683-691
50. Sourkes B. Psychotherapy. In: Holland J. (Ed). Psycho-oncology (1998), Oxford University Press, New York 946-953
51. Kersun L.S., and Kazak A.E. Prescribing practices of selective serotonin reuptake inhibitors (SSRIs) among pediatric oncologists: a single institution experience. Pediatr Blood Cancer 47 3 (2006) 339-342
52. Porrteus A., Ahmad N., Tobey D., et al. The prevalence and use of antidepressant medications in pediatric cancer patients. J Child Adol Psychopharm 16 4 (2006) 467-473
53. Gothelf D., Rubinstein M., Shemesh E., et al. Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer. J Am Acad Child Adolesc Psychiatry 44 12 (2005) 1258-1262
54. Whittington C.J., Kendall T., Fonagy P., et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363 9418 (2004) 1341-1345
55. Wilwerding M.B., Loprinzi C.L., Mailliard J.A., et al. A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer 3 2 (1995) 135-138
56. Pereira J., and Bruera E. Depression with psychomotor retardation: diagnostic challenges and the use of psychostimulants. J Palliat Med 4 1 (2001) 15-21
57. Collins J.J., Kerner J., Sentivany S., et al. Intravenous amitriptyline in pediatrics. J Pain Symptom Manage 10 6 (1995) 471-475
58. Berger A., Dukes E., Mercadante S., et al. Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care (Engl) 15 2 (2006) 138-145
59. Robinson R.F., Nahata M.C., and Olshefski R.S. Syncope associated with concurrent amitriptyline and fluconazole therapy. Ann Pharmacother 34 12 (2000) 1406-1409
60. Kazak A.E. Evidence-based interventions for survivors of childhood cancer and their families. J Pediatr Psychol 30 1 (2005) 29-39
61. Cheung A.H., Emslie G.J., and Mayes T.L. The use of antidepressants to treat depression in children and adolescents. CMAJ 174 2 (2006) 193-200
62. Mills K.C. Serotonin syndrome. A clinical update. Crit Care Clin 13 4 (1997) 763-783
63. Isbister G.K., and Buckley N.A. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 28 5 (2005) 205-214
64. Wolf S. Assisted suicide and euthanasia in children and adolescents. In: Emanual L. (Ed). Regulating how we die: the ethical, medical and legal issues surrounding assisted suicide (1998), Harvard University Press, Cambridge (UK) 92-119
65. Block S.D., and Billings J.A. Patient requests for euthanasia and assisted suicide in terminal illness. The role of the psychiatrist. Psychosomatics 36 5 (1995) 445-457
66. Stuber M., and Bursch B. Psychiatric care of the terminally ill child. In: Chochinov H., and Breitbart W. (Eds). Handbook of psychiatry in palliative medicine (2000), Oxford University Press, New York 255-264
67. Kunin H., Patenaude A., and Grier H.E. Suicide risk in pediatric cancer patients: an exploratory study. Psychooncology 4 2 (1995) 149-155
68. American Academy of Pediatrics. Committee on Bioethics and Committee on Hospital Care. Palliative care for children. Pediatrics 106 2 Pt 1 (2000) 351-357
69. Cohen J. Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 37 10 Suppl (1998) 4S-26S
70. Shemesh E., Koren-Michowitz M., Yehuda R., et al. Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. Psychosomatics 47 3 (2006) 231-239
71. Shemesh E., Lurie S., Stuber M.L., et al. A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics 105 2 (2000) E29
72. Compton S.N., March J.S., Brent D., et al. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry 43 8 (2004) 930-959
73. Averley P.A., Lane I., Sykes J., et al. An RCT pilot study to test the effects of intravenous midazolam as a conscious sedation technique for anxious children requiring dental treatment-an alternative to general anaesthesia. Br Dent J 197 9 (2004) 553-558 [discussion: 549]
74. Hosey M.T. UK national clinical guidelines in paediatric dentistry. Managing anxious children: the use of conscious sedation in paediatric dentistry. Int J Paediatr Dent 12 5 (2002) 359-372
75. McIntyre J., Robertson S., Norris E., et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 366 9481 (2005) 205-210
76. Dougherty M., and DeBaun M.R. Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain. J Pediatr 142 4 (2003) 373-376
77. Berde C., and Wolfe J. Pain, anxiety, distress, and suffering: interrelated, but not interchangeable. J Pediatr 142 4 (2003) 361-363
78. Waslick B. Psychopharmacology interventions for pediatric anxiety disorders: a research update. Child Adolesc Psychiatr Clin N Am 15 1 (2006) 51-71
79. Simeon J.G., Ferguson H.B., Knott V., et al. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry 31 1 (1992) 29-33
80. Graae F., Milner J., Rizzotto L., et al. Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33 3 (1994) 372-376
81. Witek M.W., Rojas V., Alonso C., et al. Review of benzodiazepine use in children and adolescents. Psychiatr Q 76 3 (2005) 283-296
82. Spiegel L. Pediatric psychopharmacology. In: Holland J. (Ed). Psycho-oncology (1998), Oxford University Press, New York 954-961
83. Reinblatt S.P., and Walkup J.T. Psychopharmacologic treatment of pediatric anxiety disorders. Child Adolesc Psychiatr Clin N Am 14 4 (2005) 877-908 x
84. Flament M.F., Geller D., Irak M., et al. Specificities of treatment in pediatric obsessive-compulsive disorder. CNS Spectr 12 2 Suppl 3 (2007) 43-58
85. Opler L.A., Grennan M.S., and Opler M.G. Pharmacotherapy of post-traumatic stress disorder. Drugs Today (Barc) 42 12 (2006) 803-809
86. Pitman R.K., Sanders K.M., Zusman R.M., et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51 2 (2002) 189-192
87. Famularo R., Kinscherff R., and Fenton T. Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. Am J Dis Child 142 11 (1988) 1244-1247
88. Klein R.G., Koplewicz H.S., and Kanner A. Imipramine treatment of children with separation anxiety disorder. J Am Acad Child Adolesc Psychiatry 31 1 (1992) 21-28
89. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. N Engl J Med 344 17 (2001) 1279-1285
90. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292 16 (2004) 1969-1976
91. Bernstein G.A., Borchardt C.M., Perwien A.R., et al. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry 39 3 (2000) 276-283
92. Himelstein B.P., Hilden J.M., Boldt A.M., et al. Pediatric palliative care. N Engl J Med 350 17 (2004) 1752-1762
93. Kazak A.E. Pediatric Psychosocial Preventative Health Model (PPPHM): research, practice and collaboration in pediatric family systems medicine. Fam Syst Health 24 4 (2006) 381-395